Located in Woodridge, Illinois, Advanced Life Sciences is a state-of-the-art biopharmaceutical company that is engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, cancer and respiratory diseases. One such disease that Advanced Life is fighting to combat is Tularemia.

Tularemia is a deadly bacterial disease that is commonly transmitted to humans through contact with infected rodents or through insects that carry Francisella tularensis, which is classified by the Department of Defense and Department of Health and Human Services as one of the most deadly serious biological weapons along with anthrax and plague.

Today, Advanced Life Sciences Holdings made a major announcement that has the potential to enhance the future of their company. The company stated that they received positive top-line results from a pivotal, non-human primate study of its novel, once-a-day, oral antibiotic Restanza against an inhaled lethal dose of tularemia.

Advanced

TEN, Tenneco Inc.

ADLS, Advanced Life Sciences Holdings Inc, ADLS.OB

PennyOmega.com Watch List!

PennyOmega.com Watch List ! for Tuesday September 1st, 2009

Our Picks at PennyOmega.com for Tuesday September 1st, 2009 are:

**************************************************************

TEN, Tenneco Inc.

TEN has grown to become one of the world’s leading designers, manufacturers and distributors of emission control and ride control products and systems for the automotive original equipment market and the aftermarket. The company is well-balanced across product lines, markets served and geographic regions.

Using a combination of leading-edge technology, manufacturing expertise and dedication to customer service, TEN has increased revenues to $5.9 billion annually and penetrated new markets to solidify its leadership in the global automotive supply industry. TEN is well positioned to